Global Calcium
Global Calcium Private Limited is an India-based private manufacturer of Active Pharmaceutical Ingredients, chelated mineral actives and premixes, operating 14 plants with 1,400+ employees and exporting to 80 countries under USFDA, EU-GMP and WHO cGMP certifications.
- Company typePrivate
- Founded2010
- HeadquartersBangalore, India
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Global Calcium does
Global Calcium Private Limited is an India-based, privately held manufacturer of Active Pharmaceutical Ingredients (APIs), mineral actives and premixes, headquartered in Bengaluru with manufacturing concentrated in Hosur, Tamil Nadu across 14 plants spanning 40+ acres and employing over 1,400 trained staff. The company's API portfolio targets technically demanding niches including benzodiazepines, ophthalmic APIs, oncology APIs and psychotropic/CNS-acting drugs, while its mineral actives line delivers high-purity chelated and organic mineral salts (aspartate, citrate, gluconate, lactate, lactobionate, levulinate, orotate, pidolate), including injectable-grade specifications. Premixes round out the portfolio as pre-blended ingredients for nutraceutical, pharmaceutical and food-fortification applications.
Global Calcium operates a B2B, sales-led distribution model with dedicated channels serving pharmaceutical, nutraceutical, cosmeceutical, veterinary and food-fortification customers across 80 countries. The business is anchored by a comprehensive regulatory accreditation stack — USFDA, EU-GMP, COFEPRIS, WHO cGMP, ISO 9001:2015, ISO 14001:2015, FSSC, HACCP, Kosher and Halal — supplemented by 100 global Drug Master Files and 25 USDMFs that function as the primary commercial moat. Pricing is quote-based and undisclosed, with revenue generated through one-time ingredient supply rather than licensing or recurring contracts. The company reports no parent, no subsidiaries, no disclosed institutional investors and no public listing, indicating a founder- or family-owned operating posture.
Product economics are driven by chemistry and regulatory compliance rather than software or AI; the source material contains no AI/ML capability disclosure, proprietary models or data assets. Marketing is conducted primarily through the corporate website, downloadable product brochures and DMF/regulatory documentation, with no disclosed channel partnerships, awards, patents or M&A activity in the available data.
Global Calcium firmographics
Firmographics- Name
- Global Calcium
- Legal name
- Global Calcium Private Limited
- Website
- https://globalcalcium.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Global Calcium Private Limited is an India-based private manufacturer of Active Pharmaceutical Ingredients, chelated mineral actives and premixes, operating 14 plants with 1,400+ employees and exporting to 80 countries under USFDA, EU-GMP and WHO cGMP certifications.
- Ownership category
- akta.pro rank
Global Calcium industry classification
Industry- Product category
- Active Pharmaceutical Ingredient (API) Manufacturing
- NAICS
- Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)
- akta.pro secondary industries
- Controlled Substances / DEA-Scheduled API Manufacturing (HLAGAHAD), Fortification Ingredients (Vitamins, Minerals, Nutrient Premixes) (CRADAOAM)
Keywords
Where Global Calcium is headquartered
LocationHeadquarters
- HQ city
- Bangalore
- HQ country
- India
- HQ region
- Asia
Offices3 records
Markets served
Global Calcium business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure
Revenue model
- Active Pharmaceutical Ingredients (APIs): Manufacturing and sale of specialty APIs including benzodiazepines, ophthalmic APIs, and oncology drugs to pharmaceutical companies globally
- Mineral Actives: Production and sale of high-purity mineral salts and chelated minerals including organic mineral salts of aspartate, citrate, gluconate, lactate, lactobionate, levulinate, orotate, and pidolate for pharmaceutical, nutraceutical, and cosmeceutical applications
- Premixes: Pre-formulated mineral and nutrient premixes for dietary supplement and food fortification applications
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Global Calcium product offering
Product offeringCore offering
Global Calcium manufactures and sells Active Pharmaceutical Ingredients (specialty APIs, benzodiazepines, psychotropic & CNS acting APIs, ophthalmic APIs, oncology APIs), high-purity Mineral Actives (chelated and organic mineral salts), and Premixes to pharmaceutical, nutraceutical, cosmeceutical, veterinary, and food-fortification companies. Production runs across 14 cGMP-compliant manufacturing plants in India, with regulatory documentation (CEP, EDMF, USDMF) supplied to support customers' filings in the US, EU, and other regulated markets.
Product overview
Global Calcium is a manufacturer of Active Pharmaceutical Ingredients and Mineral Actives. The company operates three core product lines: (1) APIs covering specialty APIs, benzodiazepines, psychotropic & CNS acting APIs, ophthalmic APIs, and oncology APIs; (2) Mineral Actives including chelated minerals and organic mineral salts in various forms such as aspartate, citrate, gluconate, lactate, lactobionate, levulinate, orotate, and pidolate; and (3) Premixes for pharmaceutical, nutraceutical, and food fortification applications. The company exports to 80 countries worldwide and operates 14 manufacturing plants with over 1400 employees.
Differentiator
Problem solved
Functional benefit
Products and services
- Active Pharmaceutical Ingredients (APIs) Active Pharmaceutical Ingredients including specialty APIs, benzodiazepines, psychotropic & CNS acting APIs, ophthalmic APIs, and oncology APIs manufactured at WHO cGMP accredited facilities for pharmaceutical manufacturers globally.
- Mineral Actives High-purity mineral actives including chelated minerals and organic mineral salts such as aspartate, citrate, gluconate, lactate, lactobionate, levulinate, orotate, and pidolate compounds, supplied to pharmaceutical, nutraceutical and cosmeceutical formulators.
- Premixes Pre-blended mineral and API premixes for pharmaceutical, nutraceutical, and food-fortification applications, supplied to manufacturers of dietary supplements and fortified foods.
Companies that use Global Calcium
Customer profileSegments5 records
Ideal customer profiles2 records
Global Calcium technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Global Calcium partnerships and signals
Strategic signalScale indicators7 records
Recent moves5 records
Expansion highlights5 records
Global Calcium competitors and assessment
Company assessmentDirect peers
- Divi's Laboratories: India-headquartered, publicly listed API manufacturer with global export reach and USFDA/EU-GMP facilities. Highly comparable to Global Calcium as a pure-play API producer serving regulated pharmaceutical markets worldwide.
- Ipca Laboratories: Indian manufacturer of APIs and formulations with strong export orientation and USFDA-approved facilities. Comparable to Global Calcium in API manufacturing capabilities and international market presence.
- Hikal Limited: Indian API and intermediates manufacturer serving pharmaceutical and animal health industries globally. Comparable to Global Calcium's API manufacturing focus and similar scale of operations.
- Solara Active Pharma Sciences: Pure-play Indian API manufacturer with focus on specialty APIs and multi-jurisdictional regulatory filings. Closely comparable to Global Calcium's API-only business model and certification footprint.
- Laurus Labs: Indian API and CDMO manufacturer with USFDA-approved facilities serving global pharmaceutical markets. Comparable to Global Calcium in API manufacturing capabilities, regulatory certifications, and export orientation.
- Granules India: Indian pharmaceutical manufacturer with significant API and intermediate manufacturing operations. Comparable to Global Calcium in active pharmaceutical ingredient production and global supply capabilities.
- Ami Lifesciences: Indian specialty API manufacturer focused on niche therapeutic categories with USDMF filings. Comparable to Global Calcium in specialty API positioning and regulated-market focus.
- SMS Pharmaceuticals: Indian API manufacturer with USFDA-approved facilities producing specialty APIs and intermediates. Comparable to Global Calcium in API manufacturing scale, regulatory certifications, and export business model.
- Sequent Scientific: Indian pharmaceutical company with API manufacturing capabilities serving animal health and human pharmaceutical markets. Comparable to Global Calcium's veterinary segment and broader API manufacturing focus.
Broad incumbents
- Aurobindo Pharma: Large Indian pharmaceutical company with substantial API manufacturing operations alongside finished formulations. Comparable to Global Calcium in API scale, regulatory certifications, and global distribution breadth, but operates a much broader portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Global Calcium social profiles
Digital presenceGlobal Calcium compliance and trust
Trust signalCompliance10 records
Global Calcium financial estimates
Financial estimateRevenue estimate
Valuation estimate
Global Calcium leadership team
Management profileNumber of profiles
Profiles1 record
Global Calcium funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Global Calcium M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Global Calcium
What does Global Calcium do?
Global Calcium manufactures and sells Active Pharmaceutical Ingredients (specialty APIs, benzodiazepines, psychotropic & CNS acting APIs, ophthalmic APIs, oncology APIs), high-purity Mineral Actives (chelated and organic mineral salts), and Premixes to pharmaceutical, nutraceutical, cosmeceutical, veterinary, and food-fortification companies. Production runs across 14 cGMP-compliant manufacturing plants in India, with regulatory documentation (CEP, EDMF, USDMF) supplied to support customers' filings in the US, EU, and other regulated markets.
Is Global Calcium a public or private company?
Global Calcium is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Global Calcium founded?
Global Calcium was founded in 2010. It employs 251 to 500 people.
Where is Global Calcium based?
Global Calcium is headquartered in Bangalore, India, in the Asia region.
How does Global Calcium make money?
Three revenue lines are on record. Active Pharmaceutical Ingredients (APIs) is the primary driver. The others are mineral Actives and premixes.
Who are Global Calcium's main competitors?
Direct peers on record are Divi's Laboratories, Ipca Laboratories, Hikal Limited, Solara Active Pharma Sciences, Laurus Labs, Granules India, Ami Lifesciences, SMS Pharmaceuticals and Sequent Scientific. Aurobindo Pharma is listed as a broad incumbent.
Does Global Calcium have an API?
No public API is recorded for Global Calcium.
What industry is Global Calcium in?
Global Calcium's product category is Active Pharmaceutical Ingredient (API) Manufacturing. Its primary akta.pro industry code is HLAIAJAO, Compounding Ingredient & API Distributors (Pharma Supply), with a secondary code of HLAGAHAD, Controlled Substances / DEA-Scheduled API Manufacturing. Its NAICS code is 325411 and its SIC code is 2833.